πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors β€” phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β€” searchable for business development and competitive intelligence.

4,838 results for β€œSP” Clear

  1. Vaxigrip Tetra, suspensie voor injectie in een voorgevulde spuit Quadrivalent griepvaccin (gesplitst virion, geΓ―nactiveerd), Fluenz Tetra nasal spray suspension Influenza vaccine (live attenuated, nasal)

    Disc Medicine

    healthy individuals

    approved small molecule active

    1 trial

  2. Vedolizumab

    Second Affiliated Hospital of Soochow University

    Ulcerative Colitis (UC)

    approved mab completed

    1 trial

  3. Vemlidy

    Hospital Authority, Hong Kong

    Chronic Hepatitis b

    approved small molecule active

    1 trial

  4. Vifor

    The First People's Hospital of Lianyungang

    Malnutrition

    approved small molecule completed

    1 trial

  5. Vitamin D3

    Hospital Authority, Hong Kong

    Bronchiectasis

    approved small molecule active

    1 trial

  6. Voltaren SPORT, 11,6 mg/g, ΕΌel, Voltaren MAX, 23,2 mg/g, ΕΌel

    HALEON AUSTRALIA PTY LTD

    Mild/non-serious osteoarthritis (OA) of the knee.

    approved small molecule active

    1 trial

  7. Vonoprazan

    The First People's Hospital of Lianyungang

    Helicobacter Pylori Infection

    approved small molecule active

    2 trials

  8. Vonoprazan

    The First People's Hospital of Lianyungang

    Ulcers, Gastric

    approved small molecule active

    1 trial

  9. Vonoprazan and Amoxicillin for the first 7 days

    The First People's Hospital of Lianyungang

    Helicobacter Pylori Infection

    approved small molecule active

    1 trial

  10. WARFARIN, LYSINE ASPIRIN, CLOPIDOGREL, ACETYLSALICYLIC ACID, ATORVASTATIN, DILTIAZEM, BISOPROLOL, ACETYLCHOLINE CHLORIDE, GLYCERYL TRINITRATE, RAMIPRIL

    Fondazione Telethon ETS

    Myocardial infarction with non-obstructive coronary arteries (MINOCA)

    approved small molecule active

    1 trial

  11. Wangbi granules

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Rheumatoid Arthritis

    approved small molecule active

    1 trial

  12. Warfarin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Anticoagulation

    approved small molecule active

    1 trial

  13. Wen Xin granule

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Coronary Heart Disease

    approved small molecule active

    1 trial

  14. XALKORI 200 mg hard capsules, XALKORI 250 mg hard capsules, Crizotinib 200 mg capsules, Crizotinib 250 mg capsules

    Pfizer Australia Pty Ltd

    This Master Protocol for Crizotinib Continuation Sub-Studies has been designed to provide continued treatment access for eligible participants who continue to derive clinical benefit from study intervention in a Pfizer sponsored crizotinib parent study that will be closed

    approved small molecule active

    1 trial

  15. XELJANZ 11 mg prolonged-release tablets

    Disc Medicine

    Rheumatoid arthritis or psoriatic arthritis according to respectively 2010 criteria or CASPAR criteria

    approved small molecule active

    1 trial

  16. Xiang Sha Liu Jun Zi Decoction dry powder

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatocellular Carcinoma

    approved small molecule completed

    1 trial

  17. Xingnaojing injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acute Ischemic Stroke

    approved small molecule active

    1 trial

  18. Xingnaojing injection

    The First People's Hospital of Lianyungang

    Ischemic Stroke, Acute

    approved small molecule active

    1 trial

  19. Xuebijing Injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Sepsis

    approved small molecule completed

    2 trials

  20. Xuesaitong Soft Capsule

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Coronary Heart Disease

    approved small molecule active

    2 trials

  21. Xueshuanxinmaining tablet

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Coronary Heart Disease

    approved small molecule active

    1 trial

  22. Yiqitongluo granule

    The First People's Hospital of Lianyungang

    Stroke

    approved small molecule completed

    1 trial

  23. Z-Brace interbody fusion device

    Hospital Authority, Hong Kong

    Cervical Disc Degeneration

    approved other active

    1 trial

  24. Zavicefta, Ceftazidime-Avibactam

    Pfizer

    Hospital-Acquired Pneumonia

    approved small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β€” verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources